Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy (original) (raw)

• Isfort, M., Stevens, S. C., Schaffer, S., Jong, C. J. & Wold, L. E. Metabolic dysfunction in diabetic cardiomyopathy. Heart Fail. Rev. 19, 35–48 (2014).
  Article CAS PubMed Google Scholar
• Adeghate, E. & Singh, J. Structural changes in the myocardium during diabetes-induced cardiomyopathy. Heart Fail. Rev. 19, 15–23 (2014).
  Article PubMed Google Scholar
• Dhalla, N. S., Takeda, N., Rodriguez-Leyva, D. & Elimban, V. Mechanisms of subcellular remodeling in heart failure due to diabetes. Heart Fail. Rev. 19, 87–99 (2014).
  Article CAS PubMed Google Scholar
• Velez, M., Kohli, S. & Sabbah, H. N. Animal models of insulin resistance and heart failure. Heart Fail. Rev. 19, 1–13 (2014).
  Article CAS PubMed Google Scholar
• Jia, G., Aroor, A. R., Martinez-Lemus, L. A. & Sowers, J. R. Overnutrition, mTOR signaling, and cardiovascular diseases. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R1198–R1206 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Rubler, S. et al. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am. J. Cardiol. 30, 595–602 (1972).
  Article CAS PubMed Google Scholar
• Maisch, B., Alter, P. & Pankuweit, S. Diabetic cardiomyopathy — fact or fiction? Herz 36, 102–115 (2011).
  Article CAS PubMed Google Scholar
• Voulgari, C., Papadogiannis, D. & Tentolouris, N. Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc. Health Risk Manag. 6, 883–903 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Factor, S. M., Minase, T. & Sonnenblick, E. H. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am. Heart J. 99, 446–458 (1980).
  Article CAS PubMed Google Scholar
• Falcao-Pires, I. & Leite-Moreira, A. F. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail. Rev. 17, 325–344 (2012).
  Article CAS PubMed Google Scholar
• Roberts, A. W., Clark, A. L. & Witte, K. K. Review article: left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease — do we need to screen our patients? Diab. Vasc. Dis. Res. 6, 153–163 (2009).
  Article PubMed Google Scholar
• Wong, A. K., AlZadjali, M. A., Choy, A. M. & Lang, C. C. Insulin resistance: a potential new target for therapy in patients with heart failure. Cardiovasc. Ther. 26, 203–213 (2008).
  Article CAS PubMed Google Scholar
• Aroor, A. R., Mandavia, C. H. & Sowers, J. R. Insulin resistance and heart failure: molecular mechanisms. Heart Fail. Clin. 8, 609–617 (2012).
  Article PubMed PubMed Central Google Scholar
• Witteles, R. M. & Fowler, M. B. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J. Am. Coll. Cardiol. 51, 93–102 (2008).
  Article CAS PubMed Google Scholar
• Dhalla, N. S., Pierce, G. N., Innes, I. R. & Beamish, R. E. Pathogenesis of cardiac dysfunction in diabetes mellitus. Can. J. Cardiol. 1, 263–281 (1985).
  CAS PubMed Google Scholar
• Kim, J. A., Jang, H. J., Martinez-Lemus, L. A. & Sowers, J. R. Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation. Am. J. Physiol. Endocrinol. Metab. 302, E201–E208 (2012).
  Article CAS PubMed Google Scholar
• Jia, G. et al. Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet. Hypertension 65, 531–539 (2015).
  Article CAS PubMed Google Scholar
• Kim, J. A., Wei, Y. & Sowers, J. R. Role of mitochondrial dysfunction in insulin resistance. Circ. Res. 102, 401–414 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Mandavia, C. H., Aroor, A. R., Demarco, V. G. & Sowers, J. R. Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. Life Sci. 92, 601–608 (2013).
  Article CAS PubMed Google Scholar
• Regan, T. J. Congestive heart failure in the diabetic. Annu. Rev. Med. 34, 161–168 (1983).
  Article CAS PubMed Google Scholar
• Schaffer, S. W. Cardiomyopathy associated with noninsulin-dependent diabetes. Mol. Cell. Biochem. 107, 1–20 (1991).
  Article CAS PubMed Google Scholar
• Battiprolu, P. K. et al. Diabetic cardiomyopathy and metabolic remodeling of the heart. Life Sci. 92, 609–615 (2013).
  Article CAS PubMed Google Scholar
• Mytas, D. Z. et al. Diabetic myocardial disease: pathophysiology, early diagnosis and therapeutic options. J. Diabetes Complications 23, 273–282 (2009).
  Article PubMed Google Scholar
• Harmancey, R. et al. Insulin resistance improves metabolic and contractile efficiency in stressed rat heart. FASEB J. 26, 3118–3126 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Mandavia, C. H., Pulakat, L., DeMarco, V. & Sowers, J. R. Over-nutrition and metabolic cardiomyopathy. Metabolism 61, 1205–1210 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Fang, Z. Y., Prins, J. B. & Marwick, T. H. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr. Rev. 25, 543–567 (2004).
  Article CAS PubMed Google Scholar
• Bugger, H. & Abel, E. D. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 57, 660–671 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• DeMarco, V. G., Aroor, A. R. & Sowers, J. R. The pathophysiology of hypertension in patients with obesity. Nat. Rev. Endocrinol. 10, 364–376 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Wang, J., Song, Y., Wang, Q., Kralik, P. M. & Epstein, P. N. Causes and characteristics of diabetic cardiomyopathy. Rev. Diabet. Stud. 3, 108–117 (2006).
  Article PubMed PubMed Central Google Scholar
• Dhalla, N. S., Liu, X., Panagia, V. & Takeda, N. Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc. Res. 40, 239–247 (1998).
  Article CAS PubMed Google Scholar
• Liu, J. et al. Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: hope from natural mitochondrial nutrients. Adv. Drug Deliv. Rev. 61, 1343–1352 (2009).
  Article CAS PubMed Google Scholar
• Factor, S. M. et al. Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy? Am. J. Pathol. 116, 9–20 (1984).
  PubMed PubMed Central CAS Google Scholar
• Hotamisligil, G. S. Inflammation and endoplasmic reticulum stress in obesity and diabetes. Int. J. Obes. (Lond.) 32, S52–S54 (2008).
  Article CAS Google Scholar
• Henstridge, D. C., Whitham, M. & Febbraio, M. A. Chaperoning to the metabolic party: the emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes. Mol. Metab. 3, 781–793 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Jain, S. S. et al. High-fat diet-induced mitochondrial biogenesis is regulated by mitochondrial-derived reactive oxygen species activation of CaMKII. Diabetes 63, 1907–1913 (2014).
  Article CAS PubMed Google Scholar
• Adameova, A. & Dhalla, N. S. Role of microangiopathy in diabetic cardiomyopathy. Heart Fail. Rev. 19, 25–33 (2014).
  Article PubMed Google Scholar
• Kubli, D. A. & Gustafsson, A. B. Mitochondria and mitophagy: the yin and yang of cell death control. Circ. Res. 111, 1208–1221 (2012).
  Article PubMed PubMed Central CAS Google Scholar
• Sano, R. & Reed, J. C. ER stress-induced cell death mechanisms. Biochim. Biophys. Acta 1833, 3460–3470 (2013).
  Article CAS PubMed Google Scholar
• Mei, Y., Thompson, M. D., Cohen, R. A. & Tong, X. Endoplasmic reticulum stress and related pathological processes. J. Pharmacol. Biomed. Anal. 1, 1000107 (2013).
  PubMed PubMed Central Google Scholar
• Yi, C. H., Vakifahmetoglu-Norberg, H. & Yuan, J. Integration of apoptosis and metabolism. Cold Spring Harb. Symp. Quant. Biol. 76, 375–387 (2011).
  Article CAS PubMed Google Scholar
• Jia, G. & Sowers, J. R. Autophagy: a housekeeper in cardiorenal metabolic health and disease. Biochim. Biophys. Acta 1852, 219–224 (2015).
  Article CAS PubMed Google Scholar
• Wensley, I., Salaveria, K., Bulmer, A. C., Donner, D. G. & du Toit, E. F. Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance. Exp. Physiol. 98, 1552–1564 (2013).
  Article CAS PubMed Google Scholar
• Falskov, B. et al. The effect of chronic heart failure and type 2 diabetes on insulin-stimulated endothelial function is similar and additive. Vasc. Health Risk Manag. 7, 771–776 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Xie, Z. et al. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 60, 1770–1778 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Paulus, W. J. & Tschope, C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J. Am. Coll. Cardiol. 62, 263–271 (2013).
  Article PubMed Google Scholar
• Zhou, X. et al. Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat. Hypertension 55, 880–888 (2010).
  Article PubMed CAS Google Scholar
• Hayden, M. R., Habibi, J., Joginpally, T., Karuparthi, P. R. & Sowers, J. R. Ultrastructure study of transgenic Ren2 rat aorta — part 1: endothelium and intima. CardioRenal Med. 2, 66–82 (2012).
  Article PubMed PubMed Central Google Scholar
• Blaha, M. J. et al. The relationship between insulin resistance and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 34, 749–751 (2011).
  Article PubMed PubMed Central Google Scholar
• Olesen, P., Nguyen, K., Wogensen, L., Ledet, T. & Rasmussen, L. M. Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin. Am. J. Physiol. Heart Circ. Physiol. 292, H1058–H1064 (2007).
  Article CAS PubMed Google Scholar
• Yuan, L. Q. et al. RANKL is a downstream mediator for insulin-induced osteoblastic differentiation of vascular smooth muscle cells. PLoS ONE 6, e29037 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Iyngkaran, P., Anavekar, N., Majoni, W. & Thomas, M. C. The role and management of sympathetic overactivity in cardiovascular and renal complications of diabetes. Diabetes Metab. 39, 290–298 (2013).
  Article CAS PubMed Google Scholar
• Olshansky, B., Sabbah, H. N., Hauptman, P. J. & Colucci, W. S. Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118, 863–871 (2008).
  Article PubMed Google Scholar
• Nistala, R. & Sowers, J. R. Hypertension: synergy of antihypertensives in elderly patients with CKD. Nat. Rev. Nephrol. 9, 13–15 (2013).
  Article CAS PubMed Google Scholar
• Tirosh, A., Garg, R. & Adler, G. K. Mineralocorticoid receptor antagonists and the metabolic syndrome. Curr. Hypertens. Rep. 12, 252–257 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• McMaster, W. G., Kirabo, A., Madhur, M. S. & Harrison, D. G. Inflammation, immunity, and hypertensive end-organ damage. Circ. Res. 116, 1022–1033 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Hofmann, U. & Frantz, S. Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ. Res. 116, 354–367 (2015).
  Article CAS PubMed Google Scholar
• Mori, J. et al. ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. Am. J. Physiol. Heart Circ. Physiol. 304, H1103–H1113 (2013).
  Article CAS PubMed Google Scholar
• Asrih, M. et al. Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome. Mediators Inflamm. 2013, 367245 (2013).
  PubMed PubMed Central Google Scholar
• Weirather, J. et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ. Res. 115, 55–67 (2014).
  Article CAS PubMed Google Scholar
• Sell, H., Habich, C. & Eckel, J. Adaptive immunity in obesity and insulin resistance. Nat. Rev. Endocrinol. 8, 709–716 (2012).
  Article CAS PubMed Google Scholar
• Ait-Oufella, H. et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178–180 (2006).
  Article CAS PubMed Google Scholar
• Yu, Q., Vazquez, R., Zabadi, S., Watson, R. R. & Larson, D. F. T-lymphocytes mediate left ventricular fibrillar collagen cross-linking and diastolic dysfunction in mice. Matrix Biol. 29, 511–518 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• Cao, Y., Xu, W. & Xiong, S. Adoptive transfer of regulatory T cells protects against Coxsackievirus B3-induced cardiac fibrosis. PLoS ONE 8, e74955 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• He, S., Li, M., Ma, X., Lin, J. & Li, D. CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 30, 2621–2630 (2010).
  Article CAS PubMed Google Scholar
• Erdei, T. et al. Pathophysiological rationale and diagnostic targets for diastolic stress testing. Heart 101, 1355–1360 (2015).
  Article CAS PubMed Google Scholar
• Dori, G., Rudman, M., Lichtenstein, O. & Schliamser, J. E. Ejection fraction in patients with heart failure and preserved ejection fraction is greater than that in controls — a mechanism facilitating left ventricular filling and maximizing cardiac output. Med. Hypotheses 79, 384–387 (2012).
  Article PubMed Google Scholar
• De Boeck, B. W., Cramer, M. J., Oh, J. K., van der Aa, R. P. & Jaarsma, W. Spectral pulsed tissue Doppler imaging in diastole: a tool to increase our insight in and assessment of diastolic relaxation of the left ventricle. Am. Heart J. 146, 411–419 (2003).
  Article PubMed Google Scholar
• Bostick, B. et al. Mineralocorticoid receptor blockade prevents western diet-induced diastolic dysfunction in female mice. Am. J. Physiol. Heart Circ. Physiol. 308, H1126–H1156 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Bostick, B. et al. Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity. Metabolism 63, 1000–1011 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Ernande, L. & Derumeaux, G. Diabetic cardiomyopathy: myth or reality? Arch. Cardiovasc. Dis. 105, 218–225 (2012).
  Article PubMed Google Scholar
• Battiprolu, P. K., Gillette, T. G., Wang, Z. V., Lavandero, S. & Hill, J. A. Diabetic cardiomyopathy: mechanisms and therapeutic targets. Drug Discov. Today Dis. Mech. 7, e135–e143 (2010).
  Article PubMed PubMed Central CAS Google Scholar
• D'Souza, A. et al. Chronic effects of mild hyperglycaemia on left ventricle transcriptional profile and structural remodelling in the spontaneously type 2 diabetic Goto-Kakizaki rat. Heart Fail. Rev. 19, 65–74 (2014).
  Article CAS PubMed Google Scholar
• Boudina, S. & Abel, E. D. Diabetic cardiomyopathy revisited. Circulation 115, 3213–3223 (2007).
  Article PubMed Google Scholar
• Manrique, C. et al. Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet. Endocrinology 154, 3632–3642 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Rutter, M. K. et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 107, 448–454 (2003).
  Article CAS PubMed Google Scholar
• Mihailidou, A. S. & Ashton, A. W. Cardiac effects of aldosterone: does gender matter? Steroids 91, 32–37 (2014).
  Article CAS PubMed Google Scholar
• Barrett Mueller, K. et al. Estrogen receptor inhibits mineralocorticoid receptor transcriptional regulatory function. Endocrinology 155, 4461–4472 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Chen, L. et al. Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis. Metabolism 64, 338–347 (2015).
  Article CAS PubMed Google Scholar
• Hammer, S. et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J. Am. Coll. Cardiol. 52, 1006–1012 (2008).
  Article CAS PubMed Google Scholar
• Hare, J. L. et al. Application of an exercise intervention on the evolution of diastolic dysfunction in patients with diabetes mellitus: efficacy and effectiveness. Circ. Heart Fail. 4, 441–449 (2011).
  Article PubMed Google Scholar
• Schrauwen-Hinderling, V. B. et al. Improved ejection fraction after exercise training in obesity is accompanied by reduced cardiac lipid content. J. Clin. Endocrinol. Metab. 95, 1932–1938 (2010).
  Article CAS PubMed Google Scholar
• Schrauwen-Hinderling, V. B. et al. Cardiac lipid content is unresponsive to a physical activity training intervention in type 2 diabetic patients, despite improved ejection fraction. Cardiovasc. Diabetol. 10, 47 (2011).
  Article PubMed PubMed Central CAS Google Scholar
• Nickel, A., Loffler, J. & Maack, C. Myocardial energetics in heart failure. Basic Res. Cardiol. 108, 358 (2013).
  Article CAS PubMed Google Scholar
• Senanayake, E. L. et al. Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgery. Eur. J. Cardiothorac. Surg. 48, 354–362 (2015).
  Article PubMed Google Scholar
• Gao, D., Ning, N., Niu, X., Hao, G. & Meng, Z. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure. Heart 97, 278–286 (2011).
  Article CAS PubMed Google Scholar
• Sulaiman, M. et al. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 298, H833–H843 (2010).
  Article CAS PubMed Google Scholar
• Rabassa, M., Zamora-Ros, R., Urpi-Sarda, M. & Andres-Lacueva, C. Resveratrol metabolite profiling in clinical nutrition research — from diet to uncovering disease risk biomarkers: epidemiological evidence. Ann. NY Acad. Sci. 1348, 107–115 (2015).
  Article CAS PubMed Google Scholar
• Maier, L. S. et al. RAnoLazIne for the treatment of Diastolic Heart Failure in patients with preserved ejection fraction: the RALI-DHF proof-of-concept study. JACC Heart Fail. 1, 115–122 (2013).
  Article PubMed Google Scholar
• Doehner, W., Frenneaux, M. & Anker, S. D. Metabolic impairment in heart failure: the myocardial and systemic perspective. J. Am. Coll. Cardiol. 64, 1388–1400 (2014).
  Article PubMed Google Scholar
• Dhalla, N. S., Temsah, R. M. & Netticadan, T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 18, 655–673 (2000).
  Article CAS PubMed Google Scholar
• Xu, Y. J., Tappia, P. S., Neki, N. S. & Dhalla, N. S. Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants. Heart Fail. Rev. 19, 113–121 (2014).
  Article CAS PubMed Google Scholar
• Szeto, H. H. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br. J. Pharmacol. 171, 2029–2050 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Huynh, K. et al. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes. Diabetologia 55, 1544–1553 (2012).
  Article CAS PubMed Google Scholar
• Mortensen, S. A. et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2, 641–649 (2014).
  Article PubMed Google Scholar
• Mamas, M. A. et al. Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated? J. Card. Fail. 16, 761–768 (2010).
  Article CAS PubMed Google Scholar
• Sacca, L. Heart failure as a multiple hormonal deficiency syndrome. Circ. Heart Fail. 2, 151–156 (2009).
  Article PubMed Google Scholar
• Sacca, L. & Napoli, R. Insulin resistance in chronic heart failure: a difficult bull to take by the horns. Nutr. Metab. Cardiovasc. Dis. 19, 303–305 (2009).
  Article CAS PubMed Google Scholar
• von Bibra, H. & St John Sutton, M. Impact of diabetes on postinfarction heart failure and left ventricular remodeling. Curr. Heart Fail. Rep. 8, 242–251 (2011).
  Article PubMed PubMed Central Google Scholar
• Wong, A. K. et al. The effect of metformin on insulin resistance and exercise parameters in patients with heart failure. Eur. J. Heart Fail. 14, 1303–1310 (2012).
  Article CAS PubMed Google Scholar
• Kolwicz, S. C. Jr., Purohit, S. & Tian, R. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ. Res. 113, 603–616 (2013).
  Article CAS PubMed Google Scholar
• Inzucchi, S. E. et al. SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials. Diab. Vasc. Dis. Res. 12, 90–100 (2015).
  Article PubMed CAS Google Scholar
• Zinman, B. et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. http://dx.doi.org/10.1056/NEJMoa1504720 (2015).
• Huynh, K., Bernardo, B. C., McMullen, J. R. & Ritchie, R. H. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways. Pharmacol. Ther. 142, 375–415 (2014).
  Article CAS PubMed Google Scholar
• Drawnel, F. M. et al. Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells. Cell Rep. 9, 810–821 (2014).
  Article CAS PubMed Google Scholar
• Meloni, M. et al. Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice. Diabetes 61, 229–240 (2012).
  Article CAS PubMed Google Scholar
• Katare, R. et al. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ. Res. 108, 1238–1251 (2011).
  Article CAS PubMed Google Scholar
• Greco, S. et al. MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes 61, 1633–1641 (2012).
  Article PubMed PubMed Central CAS Google Scholar